FDA.reportPublic FDA data

taletrectinib 200 MG Oral Capsule [Ibtrozi]

RxCUI
2716931
RxNorm name
taletrectinib 200 MG Oral Capsule [Ibtrozi]
Display name
taletrectinib 200 MG Oral Capsule [Ibtrozi]
Full name
taletrectinib 200 MG Oral Capsule [Ibtrozi]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:58

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
51ac8e52-3269-4102-8dc8-dba22d82128cIBTROZI 200 MG Oral Capsule [PSN] · taletrectinib 200 MG Oral Capsule [Ibtrozi] [SBD] · Ibtrozi 200 MG (as taletrectinib adipate 272 MG) Oral Capsule [SY]34These highlights do not include all the information needed to use IBTROZI safely and effectively. See full prescribing information for IBTROZI. IBTROZI ® (taletrectinib) capsules, for oral use Initial U.S. Approval: 202520260323